Filing Details
- Accession Number:
- 0001209191-21-027460
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-19 21:00:18
- Reporting Period:
- 2021-04-15
- Accepted Time:
- 2021-04-19 21:00:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1664106 | Logicbio Therapeutics Inc. | LOGC | Biological Products, (No Disgnostic Substances) (2836) | 471514975 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831341 | Kyle Chiang | C/O Logicbio Therapeutics, Inc. 65 Hayden Ave, Floor 2 Lexington MA 02421 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-15 | 9,360 | $0.00 | 26,364 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-16 | 2,977 | $5.73 | 23,387 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2021-04-15 | 9,360 | $0.00 | 9,360 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company").
- Relates to shares sold at a weighted average price of $5.73 per share to cover tax withholding obligations in connection with the vesting of RSUs. Shares were sold in multiple transactions at prices ranging from $5.68 to $5.89, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- All of the RSUs vested on April 15, 2021, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan.
Billionaire Hedge Funds
